Bristol-Myers Squibb Co. (NYSE:BMY) currently has a daily average trading volume of 12.51M but it saw 5832172 shares traded in last market. With a market cap of 107.57B USD, the company’s current market price of $53.06 came rising about 0.57 while comparing to the previous closing price of $52.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $56.77 and as low as $39.35. In the recent trading on the day, stock has struck highest price mark of $52.535 while lowest mark touched by it was $53.11.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Bernstein which initiated the stock as “Mkt Perform” in its note to investors issued on October 17, 2024, recommending a price target of $56 for it. Barclays downgraded its recommendation for the stock as a “Equal Weight” from “Overweight” on July 29, 2024 while assigning a price target of $41.
Over the week, BMY’s stock price is moving -0.58% down while it is 4.16% when we observe its performance for the past one month. Year-to-date it is 3.41% up and over the past year, the stock is showing a downside performance of -5.25%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 1.82 beat the consensus estimate of 1.61 for the same. The company is expected to be releasing its next quarterly report on 2024-Oct-31, for which analysts forecasted an EPS of 1.5 while estimate for next year EPS is 0.71. In next quarter, company is expected to be making quarterly sales of $11.47B as analysts are expecting the sales for current fiscal year at $46.76B and seeing the company making $46.51B in sales next year. Moreover, analysts are in estimates of $11.27B for current-quarter revenue.
Currently, Bristol-Myers Squibb Co.’s total number of outstanding shares is 2.03B with 0.11% of that held by the insiders while 79.28% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -9.72% and return on equity (ROE) at -26.70%. It has a 7.64 of forward P/E ratio. Stock’s beta reads 0.45. Stock has a price to book (P/B) ratio of 6.32 while price to sale or P/S ratio amounts to 2.31. Its return on asset (ROA) is -6.95% on average.
